SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-045288
Filing Date
2021-08-20
Accepted
2021-08-20 16:19:21
Documents
12
Period of Report
2021-08-17
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K reta-8k_20210817.htm   iXBRL 8-K 35289
  Complete submission text file 0001564590-21-045288.txt   161200

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA reta-20210817.xsd EX-101.SCH 5772
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE reta-20210817_lab.xml EX-101.LAB 18734
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE reta-20210817_pre.xml EX-101.PRE 11172
5 EXTRACTED XBRL INSTANCE DOCUMENT reta-8k_20210817_htm.xml XML 3428
Mailing Address 5320 LEGACY DRIVE PLANO TX 75024
Business Address 5320 LEGACY DRIVE PLANO TX 75024 972-865-2219
REATA PHARMACEUTICALS INC (Filer) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37785 | Film No.: 211194075
SIC: 2834 Pharmaceutical Preparations